Sinemet (MSD) is a combined preparation each tablet of which contains levodopa 250 mg and carbidopa 25 mg. It is used for the treatment of Parkinsonism. Levodopa is now established as the best treatment for Parkinsonism. Carbidopa (L-α-methyldopahydrazine) is a peripherally acting dopa-decarboxylase inhibitor which blocks the normal metabolism of levodopa outside the central nervous system.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.